🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate and compare the efficacy and safet...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00276458
Treatments Being Tested
A study to assess the effectiveness and tolerability of MK0653A and MK0653A...
Status
Completed
Location
Multiple Locations
Start Date
2005-01-19
Trial ID
NCT00541697
The study is a placebo-controlled, double-blind, randomized, phase 3 study ...
Status
Completed
Location
East Valley Diabetes & Endocrinology
Start Date
2024-03-01
Trial ID
NCT06005597
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab...
Status
Completed
Location
H Plus Yangji Hospital
Start Date
2022-01-01
Trial ID
NCT06225635
Treatments Being Tested
The chief aim of SHARP was to determine whether lowering blood LDL choleste...
Status
Completed
Location
Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford
Start Date
2003-06
Trial ID
NCT00125593
Treatments Being Tested
A 6-week clinical trial in patients with metabolic syndrome and hypercholes...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00409773
Treatments Being Tested
This study aims to investigate the lipid-lowering effects and safety of adm...
Status
Completed
Location
Korea University Anam Hospital
Start Date
2022-02-28
Trial ID
NCT06866509
Treatments Being Tested
The main purpose of this study is to assess whether enlicitide is superior ...
Status
Completed
Location
Clinical Trials Research ( Site 1509)
Start Date
2024-07-08
Trial ID
NCT06450366
This is a multicenter study to evaluate the safety and efficacy of ezetimib...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-01
Trial ID
NCT00479713
The intent of this study is to demonstrate that single doses of the Final M...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01236430